Virilizing Ovarian Tumor of Low Malignant Potential Associated with Antecedent Tamoxifen Use for Breast Cancer

Author： Surbek D.V.   Hoesli I.   Torhorst J.   Almendral A.C.   Dellas A.   Holzgreve W.  

Publisher： Elsevier

ISSN： 0090-8258

Source： Gynecologic Oncology, Vol.68, Iss.3, 1998-03, pp. : 293-296

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Ovarian Histopathology in Breast Cancer Patients Receiving Tamoxifen

By McGonigle K.F.   Vasilev S.A.   Odom-Maryon T.   Simpson J.F.  

Gynecologic Oncology, Vol. 73, Iss. 3, 1999-06 ,pp. : 402-406

Elsevier

Access to resources Recommend Favorite

Possible Metaplastic Origin of Lymph Node “Metastases” in Serous Ovarian Tumor of Low Malignant Potential (Borderline Serous Tumor)

By Kadar N.   Krumerman M.  

Gynecologic Oncology, Vol. 59, Iss. 3, 1995-12 ,pp. : 394-397

Academic Press

Access to resources Recommend Favorite

Malignant Endometrial Polyps in Postmenopausal Breast Cancer Tamoxifen-Treated Patients

By Cohen I.   Bernheim J.   Azaria R.   Tepper R.   Sharony R.   Beyth Y.  

Gynecologic Oncology, Vol. 75, Iss. 1, 1999-10 ,pp. : 136-141

Elsevier

Access to resources Recommend Favorite

Surgical staging of ovarian low malignant potential tumors

By Leiserowitz Gary  

The Women's Oncology Review, Vol. 5, Iss. 1, 2005-03 ,pp. : 29-30

Informa Healthcare

Access to resources Recommend Favorite

Ovarian Volume in Postmenopausal Breast Cancer Patients Treated with Tamoxifen

By Cohen I.   Altaras M.M.   Beyth Y.   Zalel Y.   Shapira J.   Yigael D.   Tepper R.  

Gynecologic Oncology, Vol. 64, Iss. 1, 1997-01 ,pp. : 105-108

Elsevier

Access to resources Recommend Favorite